A pharmacokinetic modeling of inorganic arsenic : A short-term oral exposure model for humans

Chemosphere

Volumn 39, Issue 15, 1999, Pages 2737-2747

  Yu, Donghan ^a  

^a Korea Atomic Energy Research Institute   (South Korea)

Author keywords

Health risk assessment; Inorganic arsenic; Physiologically based pharmacokinetic model; Short term oral exposures

Indexed keywords

ARSENIC; ARSENIC DERIVATIVE; ARSENIC TRIOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BLOOD FLOW; BODY DISTRIBUTION; CHEMICAL REACTION KINETICS; CHILD; EXCRETION; EXPOSURE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; METABOLITE; METAL METABOLISM; METHYLATION; MICHAELIS MENTEN KINETICS; NONHUMAN; NORMAL HUMAN; RISK ASSESSMENT; RODENT; TISSUE DISTRIBUTION; TISSUE LEVEL; WATER CONTAMINATION; WATER INTOXICATION;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; ARSENIC; HUMANS; MODELS, BIOLOGICAL; RISK ASSESSMENT; TISSUE DISTRIBUTION;

EID: 0033485419     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0045-6535(99)00207-6     Document Type: Article

References (15)

1. EPA, Health Assessment Document for Inorganic Arsenic (Final Report), EPA/600/8-83/021F, U.S. Environmental Protection Agency, Washington, D.C. (1984).
2. A.H. Smith, C. Hopenhayn-Rich, M.N. Bates, H.M. Goeden, I. Hertz-Picciotto, H.M. Duggan, R. Wood, M.J. Kosnett, and M.T. Smith, Cancer risks from arsenic in drinking water, Environ. Hlth Perspec. 97, 259-267 (1992).
3. D.S. Riggs, The Mathematical Approach to Physiological Problems: A Critical Primer, MIT Press, Cambridge (1963).
4. D. Yu, Uncertainty in a Pharmacokinetic Modeling for Inorganic Arsenic, J. Environ. Sci. Health, A33(7), 1369-1390 (1998).
5. B. Georis, A. Cardenedas, J.P. Buchet and R. Lauwerys, Inorganic arsenic methylation by rat tissue slices, Toxicology 63, 73 -84 (1990).
6. R.W. D' Souza, W.R. Francis and M.E. Andersen, Physiological model for tissue glutathione depletion and increased resynthesis after ethylene dichloride exposure, J. Pharma. Exper. Ther. 245, 563 - 568 (1988).
7. S. Husain and K.M. Ahmed, Tissue glutathione levels in mice treated with delta-9-terathydrocannabinol, Pharma. Biochem. Behav. 40, 513 - 515 (1991).
8. J.J. Saady, R.V. Blanke and A. Poklis, Estimation of the body burden of arsenic in a child fatally poisoned by arsenate weed killer, J. Analyt. Toxicol. 13, 310 - 312 (1989).
9. R.H. Reitz, A.L. Mendrala, R.A. Corley, J.F. Quast, M.L. Gargas, M.E. Anderson, D.A. Staats and R.B. Conolly, Estimating the risk of liver cancer associated with human exposure to chloroform using physiologically-based pharmacokinetic modeling, Toxicol. Appl. Pharmacol. 105, 443 - 459 (1990).
10. Y. Odanaka, O. Matano and S. Goto, Biomethylation of inorganic arsenic by the rat and some laboratory animals, Bull. Environ. Contam. Toxicol. 24, 452 - 459 (1980).
11. J.P. Buchet, R. Lauwerys and H. Roels, Comparison of the urinary excretion of arsenic metabolites after a single dose of sodium arsenite, monomethylarsenate, or dimethylarsenate in man, Int. Arch. Occup. Environ. Health 48, 71 - 79 (1981).
12. D. Pilon, A.E. Roberts and D.E. Richert, Effect of glutathione depletion on the irreversible association of acrylonitrile with tissue macromolecules after oral adiminstration to rats, Toxicol. Appl. Pharmacol. 95, 311 - 320 (1988).
13. L.R. Johnson and J.G. Farmer, Use of human metabolic studies and urinary arsenic speciation in assessing arsenic exposure, Bull. Environ. Contam. Toxico. 46, 53-61 (1991).
14. B.A. Fowler (Editor), Biological and Environmental Effects of Arsenic: Topics in Environmental Health Vol. 6, Chapter 5, Elsevier, Armsterdom (1983).
15. C. Pomroy, S.M. Charbonnaeu, R.S. McCullough and G.K.H. Tam, Human retention studies with 74As, Toxicol. Appl. Pharmacol. 53, 550-556 (1980).